Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
Palmerini, Tullio
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. [electronic resource] - European heart journal 04 2017 - 1034-1043 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1522-9645
10.1093/eurheartj/ehw627 doi
Acute Coronary Syndrome--mortality
Analysis of Variance
Aspirin--administration & dosage
Blood Vessel Prosthesis Implantation--methods
Clopidogrel
Coronary Artery Disease--mortality
Death, Sudden, Cardiac--epidemiology
Drug Administration Schedule
Drug Therapy, Combination
Drug-Eluting Stents
Female
Graft Occlusion, Vascular--etiology
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Myocardial Infarction--mortality
Myocardial Revascularization--methods
Platelet Aggregation Inhibitors--administration & dosage
Purinergic P2Y Receptor Antagonists--administration & dosage
Randomized Controlled Trials as Topic
Risk Assessment
Stroke--mortality
Ticlopidine--administration & dosage
Treatment Outcome
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. [electronic resource] - European heart journal 04 2017 - 1034-1043 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1522-9645
10.1093/eurheartj/ehw627 doi
Acute Coronary Syndrome--mortality
Analysis of Variance
Aspirin--administration & dosage
Blood Vessel Prosthesis Implantation--methods
Clopidogrel
Coronary Artery Disease--mortality
Death, Sudden, Cardiac--epidemiology
Drug Administration Schedule
Drug Therapy, Combination
Drug-Eluting Stents
Female
Graft Occlusion, Vascular--etiology
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Myocardial Infarction--mortality
Myocardial Revascularization--methods
Platelet Aggregation Inhibitors--administration & dosage
Purinergic P2Y Receptor Antagonists--administration & dosage
Randomized Controlled Trials as Topic
Risk Assessment
Stroke--mortality
Ticlopidine--administration & dosage
Treatment Outcome